Stocktoria
Arcutis Biotherapeutics, Inc. ARQT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-01-31
Arcutis Biotherapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 8,622,618 | $80.2M | 6.78% |
| D. E. Shaw & Co., Inc. | 2,496,222 | $58.8M | 1.96% |
| Point72 Asset Management, L.P. | 590,877 | $13.9M | 0.46% |
| AQR CAPITAL MANAGEMENT LLC | 468,253 | $11.0M | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 440,999 | $10.4M | 0.35% |
| TWO SIGMA INVESTMENTS, LP | 234,307 | $5.5M | 0.18% |
| CITADEL ADVISORS LLC | 98,206 | $2.3M | 0.08% |
| MILLENNIUM MANAGEMENT LLC | 49,333 | $1.2M | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.